Atos develops Space Situational Awareness Center for the German Armed Forces
April 04, 2022 04:15 ET
|
Atos International
New digital platform to secure Germany’s national space infrastructure Munich, April 4, 2022 - Atos and the European multi-national space technology company OHB have been awarded a...
Muscle Maker Signs 40 Unit Franchise Deal
November 01, 2021 08:30 ET
|
Muscle Maker, Inc.
Muscle Maker Grill continues rapid expansion with Saudi Arabia deal. This represents the second international agreement after 10-unit Kuwait agreement. Deal, if fully executed, could potentially...
vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer
June 22, 2021 07:30 ET
|
vTv Therapeutics Inc.; Cantex Pharmaceuticals, Inc.
HIGH POINT, N.C. and WESTON, Fla., June 22, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (“vTv”, Nasdaq:VTVT) and Cantex Pharmaceuticals, Inc. (“Cantex”) today announced that they have entered...
GrandVision announces that all regulatory approvals for closing of the transaction between EssilorLuxottica and HAL have been obtained
June 10, 2021 13:30 ET
|
GrandVision Retail Holding B.V.
Schiphol, The Netherlands, 10 June 2021. GrandVision (Euronext: GVNV) confirms that today the Turkish competition regulator (Rekabet Kurumu) has cleared the transaction between EssilorLuxottica SA...
WEINGARTEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of WRI and Encourages Investors to Contact the Firm
April 15, 2021 14:04 ET
|
Bragar Eagel & Squire
NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
Cend Therapeutics and Qilu Pharmaceutical Announce Partnership
February 16, 2021 08:00 ET
|
Cend Therapeutics Inc.
SAN DIEGO and JINAN, China, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Cend Therapeutics, Inc., a clinical-stage biotech company, and Qilu Pharmaceutical, a major Chinese pharmaceutical company, announced...
OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm
January 22, 2021 16:46 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
COHERENT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of COHR and Encourages Investors to Contact the Firm
January 19, 2021 11:51 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
CANTEL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CMD and Encourages Investors to Contact the Firm
January 12, 2021 12:22 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
FBL FINANCIAL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FFG and Encourages Investors to Contact the Firm
January 11, 2021 17:05 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of FBL...